2024 Q4 Form 10-Q Financial Statement

#000147793224006974 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $267.3K $1.209M
YoY Change -77.88% 5.2%
Cost Of Revenue $222.9K $446.8K
YoY Change -50.12% 7.13%
Gross Profit $44.48K $761.9K
YoY Change -94.16% 4.1%
Gross Profit Margin 16.64% 63.03%
Selling, General & Admin $600.4K
YoY Change 7.25%
% of Gross Profit 78.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.001K $7.260K
YoY Change -58.66% 11.69%
% of Gross Profit 6.75% 0.95%
Operating Expenses $352.9K $600.4K
YoY Change -41.21% 7.26%
Operating Profit -$308.5K $161.5K
YoY Change -290.98% -6.18%
Interest Expense $16.27K
YoY Change -3112.96%
% of Operating Profit 10.07%
Other Income/Expense, Net $5.432K $16.27K
YoY Change -66.61%
Pretax Income -$303.0K $177.8K
YoY Change -270.45% 3.6%
Income Tax -$79.36K $48.19K
% Of Pretax Income 27.11%
Net Earnings -$223.7K $129.6K
YoY Change -272.59% -45.81%
Net Earnings / Revenue -83.67% 10.72%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 34.51M shares 34.51M shares 34.51M shares
Diluted Shares Outstanding 34.51M shares 34.51M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.395M
YoY Change -19.6%
Cash & Equivalents $510.5K $1.395M
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables $158.2K $677.3K
Other Receivables $111.8K
Total Short-Term Assets $2.792M $3.809M
YoY Change -26.68% 14.5%
LONG-TERM ASSETS
Property, Plant & Equipment $28.24K $36.67K
YoY Change -22.99% -29.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $28.24K $36.67K
YoY Change -22.99% -82.18%
TOTAL ASSETS
Total Short-Term Assets $2.792M $3.809M
Total Long-Term Assets $28.24K $36.67K
Total Assets $2.821M $3.845M
YoY Change -26.65% 8.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $283.0K
YoY Change 158.98%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $172.9K $416.0K
YoY Change -58.44% -24.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $172.9K $416.0K
Total Long-Term Liabilities $0.00
Total Liabilities $357.8K $761.8K
YoY Change -53.03% -9.08%
SHAREHOLDERS EQUITY
Retained Earnings $2.365M $2.986M
YoY Change -20.79% 14.99%
Common Stock $34.51K $34.51K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.463M $3.084M
YoY Change
Total Liabilities & Shareholders Equity $2.821M $3.845M
YoY Change -26.65% 8.87%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$223.7K $129.6K
YoY Change -272.59% -45.81%
Depreciation, Depletion And Amortization $3.001K $7.260K
YoY Change -58.66% 11.69%
Cash From Operating Activities $210.8K
YoY Change -191.16%
INVESTING ACTIVITIES
Capital Expenditures $2.070K
YoY Change -70.97%
Acquisitions
YoY Change
Other Investing Activities $1.200K
YoY Change
Cash From Investing Activities -$870.00
YoY Change -87.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 210.8K
Cash From Investing Activities -870.0
Cash From Financing Activities
Net Change In Cash 209.9K
YoY Change -188.07%
FREE CASH FLOW
Cash From Operating Activities $210.8K
Capital Expenditures $2.070K
Free Cash Flow $208.7K
YoY Change -187.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34505520 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001088638
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34505520 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34505520 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34505520 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity File Number
EntityFileNumber
000-26533
dei Entity Registrant Name
EntityRegistrantName
MASTERMIND, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3807447
dei Entity Address Address Line1
EntityAddressAddressLine1
2221 Peachtree Rd. NE
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite D-134
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30309
dei City Area Code
CityAreaCode
678
dei Local Phone Number
LocalPhoneNumber
420-4000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34505520 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
510541 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137010 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
158164 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
254329 usd
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2093490 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
1679929 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30274 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29198 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2792469 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3100466 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28242 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37898 usd
CY2024Q3 us-gaap Assets
Assets
2820711 usd
CY2023Q4 us-gaap Assets
Assets
3138364 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
112949 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
213120 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
59955 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
121196 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
172904 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334316 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
184940 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
223691 usd
CY2024Q3 us-gaap Liabilities
Liabilities
357844 usd
CY2023Q4 us-gaap Liabilities
Liabilities
558007 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
34506 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
34506 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62865 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
62865 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2365496 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2482986 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2462867 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2580357 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2820711 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3138364 usd
CY2024Q3 us-gaap Revenues
Revenues
267345 usd
CY2023Q3 us-gaap Revenues
Revenues
1208758 usd
us-gaap Revenues
Revenues
1878272 usd
us-gaap Revenues
Revenues
3665053 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
222867 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
446843 usd
us-gaap Cost Of Revenue
CostOfRevenue
800910 usd
us-gaap Cost Of Revenue
CostOfRevenue
1405262 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
44478 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
761915 usd
us-gaap Gross Profit
GrossProfit
1077362 usd
us-gaap Gross Profit
GrossProfit
2259791 usd
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
108225 usd
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
220725 usd
us-gaap Management Fee Expense
ManagementFeeExpense
415925 usd
us-gaap Management Fee Expense
ManagementFeeExpense
642075 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
22449 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
87485 usd
us-gaap Professional Fees
ProfessionalFees
94126 usd
us-gaap Professional Fees
ProfessionalFees
153881 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
141766 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
202068 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
492897 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
593597 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80508 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90114 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
252153 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
344304 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
352948 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
600392 usd
us-gaap Operating Expenses
OperatingExpenses
1255101 usd
us-gaap Operating Expenses
OperatingExpenses
1733857 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-308470 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
161523 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-177739 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
525934 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
5432 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
16267 usd
us-gaap Interest Income Other
InterestIncomeOther
21498 usd
us-gaap Interest Income Other
InterestIncomeOther
26839 usd
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-329 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5432 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
16267 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21498 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26510 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-303038 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
177790 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-156241 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
552444 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-79360 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48193 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-38751 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
149485 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-223678 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
129597 usd
us-gaap Net Income Loss
NetIncomeLoss
-117490 usd
us-gaap Net Income Loss
NetIncomeLoss
402959 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34505520 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34505520 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34505520 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34505520 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34505520 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34505520 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34505520 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34505520 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
2580357 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
47650 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2628007 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
58538 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
2686545 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-223678 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2462867 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2680676 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
118118 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2798794 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
155244 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2954038 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
129597 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3083635 usd
us-gaap Profit Loss
ProfitLoss
117490 usd
us-gaap Profit Loss
ProfitLoss
-402959 usd
us-gaap Depreciation
Depreciation
9656 usd
us-gaap Depreciation
Depreciation
11288 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-329 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-38751 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
48630 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-96165 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
239201 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
413561 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
492434 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-77477 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1076 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
80392 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-100171 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
199816 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-61241 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-238719 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-626469 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-310247 usd
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 usd
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
1200 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8646 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7446 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-626469 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-317693 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1137010 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1712771 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
510541 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395078 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
1278 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
23378 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Mastermind, Inc. (the “Company”, “we”, “us”, or the “organization”) is an involvement marketing service agency that designs, creates and develops branding and marketing campaigns, primarily for large corporate clients with well-known brands. We specialize in customer conversion initiatives that we believe facilitate the involvement of more of the “right customers” with the brands of our clients. We focus on converting prospects to customers. Our programs can take on various forms, including creating and managing content marketing, influencer marketing, social marketing/community management, digital issues management communications, promotions, Augmented Reality Marketing, and UX Analytics &amp; Digital Intelligence.</p>
CY2024Q3 us-gaap Cash
Cash
107991 usd
CY2023Q4 us-gaap Cash
Cash
60824 usd
CY2024Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
402550 usd
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1076186 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
510541 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1137010 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Deposit Liability Uninsured
DepositLiabilityUninsured
153000 usd
CY2024Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2100000 usd
CY2024Q3 mmnd Related Party Transaction Expenses With Related Party
RelatedPartyTransactionExpensesWithRelatedParty
157681 usd
mmnd Related Party Transaction Expenses With Related Party
RelatedPartyTransactionExpensesWithRelatedParty
572326 usd
CY2023Q3 mmnd Related Party Transaction Expenses With Related Party
RelatedPartyTransactionExpensesWithRelatedParty
280577 usd
mmnd Related Party Transaction Expenses With Related Party
RelatedPartyTransactionExpensesWithRelatedParty
821366 usd
CY2024Q3 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
93135 usd
CY2023Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
93135 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64893 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
55237 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28242 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37898 usd
CY2024Q3 us-gaap Depreciation
Depreciation
3001 usd
us-gaap Depreciation
Depreciation
9656 usd
CY2023Q3 us-gaap Depreciation
Depreciation
3635 usd
us-gaap Depreciation
Depreciation
11288 usd
CY2024Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2100000 usd
CY2024Q3 mmnd Finite Lived Intangible Assets Amortization Expense License
FiniteLivedIntangibleAssetsAmortizationExpenseLicense
27000 usd
mmnd Finite Lived Intangible Assets Amortization Expense License
FiniteLivedIntangibleAssetsAmortizationExpenseLicense
81000 usd
CY2023Q3 mmnd Finite Lived Intangible Assets Amortization Expense License
FiniteLivedIntangibleAssetsAmortizationExpenseLicense
27000 usd
mmnd Finite Lived Intangible Assets Amortization Expense License
FiniteLivedIntangibleAssetsAmortizationExpenseLicense
81000 usd
CY2022Q1 mmnd Loss Contingency Damages Sought Shares Of Common Stock
LossContingencyDamagesSoughtSharesOfCommonStock
3000000 shares
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1098574 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
125000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34505520 shares

Files In Submission

Name View Source Status
mmnd-20240930_pre.xml Edgar Link unprocessable
0001477932-24-006974-index-headers.html Edgar Link pending
0001477932-24-006974-index.html Edgar Link pending
0001477932-24-006974.txt Edgar Link pending
0001477932-24-006974-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmnd-20240930.xsd Edgar Link pending
mmnd_10q.htm Edgar Link pending
mmnd_ex311.htm Edgar Link pending
mmnd_ex312.htm Edgar Link pending
mmnd_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mmnd-20240930_cal.xml Edgar Link unprocessable
mmnd-20240930_def.xml Edgar Link unprocessable
mmnd_10q_htm.xml Edgar Link completed
mmnd-20240930_lab.xml Edgar Link unprocessable